vaccine

Reuters exclusive – France won’t buy vaccines through WHO’s COVAX scheme – ministry source

France will provide funding for an initiative led by the World Health Organization to buy potential COVID-19 vaccines, but will not source shots through the programme, an official at the…

Read More Here

Russia seals another deal to supply and test its coronavirus vaccine abroad

Russia's sovereign wealth fund will supply 100 million doses of its potential coronavirus vaccine to Indian drug company Dr Reddy's Laboratories , the fund announced, as Moscow speeds up plans…

Read More Here

China’s Sinovac to test coronavirus vaccine candidate in teenagers, children

Chinese vaccine maker Sinovac Biotech plans to start a clinical trial of its experimental coronavirus vaccine with children and adolescents later this month, widening its test on a shot that's…

Read More Here

AstraZeneca’s trial illnesses may not be due to COVID-19 shot – Oxford University

The adverse events that led to a pause in trials evaluating AstraZeneca Plc's COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining…

Read More Here

Italy could have AstraZeneca COVID-19 vaccine by end November

Italy could have its first shots of British drugmaker AstraZeneca's potential COVID-19 vaccine by the end of November, the managing director of IRBM told Reuters. Biotech firm IRBM, whose lab…

Read More Here

Trump says coronavirus vaccine could be weeks away

U.S. President Donald Trump on Tuesday said a vaccine against the deadly coronavirus could be three or four weeks away, despite cautionary notes sounded by some U.S. public health officials…

Read More Here

Pfizer says late-stage coronavirus vaccine study shows moderate side effects

Pfizer Inc said on Tuesday participants were showing mild-to-moderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing late-stage study. Over 12,000 study…

Read More Here

Germany plans voluntary vaccination for mid-2021

Germany aims to reach herd immunity through a voluntary coronavirus vaccine expected to be widely available by mid-2021, the health minister said Tuesday. Speaking to reporters in Berlin, minister Jens…

Read More Here

Valneva to supply up to 190 million doses of COVID-19 vaccine to UK

French vaccine maker Valneva said on Monday it would supply the UK with up to 190 million doses of its coronavirus vaccine candidate, VLA2001, over a five-year period. Under the…

Read More Here

EU medical register shows AstraZeneca’s UK COVID-19 vaccine trials restarted

AstraZeneca's British clinical trials of its COVID-19 vaccine, one of the most advanced in development, resumed on Monday, according to the European clinical trials database EudraCT. The trial's status changed…

Read More Here

WHO head urges rich nations to join vaccine scheme by Friday deadline

Countries should join the World Health Organization's (WHO) COVAX vaccine facility by a Friday deadline to help ensure that immunizations are fairly and efficiently distributed, WHO Director General Tedros Adhanom…

Read More Here

J&J unit to start mid-stage COVID-19 vaccine trials in Spain

Johnson & Johnson's Janssen unit will begin mid-stage trials of its COVID-19 vaccine in Spain on Monday, the programme's lead investigator said. Alberto Borobia said 190 people would take part…

Read More Here

More than 1 billion people to get Russia’s COVID-19 vaccine in 2020-2021

Russia's sovereign wealth fund said that more than one billion people would receive its COVID-19 vaccine "Sputnik-V" in 2020-21, the Interfax news agency reported. The Russian Direct Investment Fund (RDIF)…

Read More Here

Merck starts recruitment for COVID-19 vaccine trial

U.S. drug maker Merck & Co Inc has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database clinicaltrials.gov. The phase 1/2 trial, which is based…

Read More Here

WHO says $700 million raised so far for COVID-19 vaccines initiative for poor

International donors have raised $700 million - less than half the target - to purchase future coronavirus vaccines for poor countries in a global initiative to ensure eventual vaccines do…

Read More Here

Russia’s RDIF agrees to manufacture Covid-19 vaccine in Brazil

Russia's sovereign wealth fund RDIF announced that it had agreed to manufacture Russia's first registered COVID-19 vaccine "Sputnik-V" in Brazil. RDIF, which is backing the vaccine's development, also said it…

Read More Here

Global study finds Covid vaccine confidence volatile, vulnerable to misinformation

Political polarisation and online misinformation are threatening vaccination programmes worldwide, with public trust volatile and varying widely between countries, according to a global vaccine confidence study. The study, which maps…

Read More Here

AstraZeneca vaccine trial pause a “wake-up call”, says WHO

AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a "wake-up call" but should not discourage researchers, the World Health Organization's (WHO) chief…

Read More Here

Brazil trials of Sinovac COVID-19 vaccine show promising results

The governor of Brazil’s São Paulo state said on Wednesday that Phase 3 clinical trials of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd have shown promising results…

Read More Here

Some scientists question Russia Sputnik-V vaccine data

Twenty-six scientists, most of them working at universities in Italy, have signed an open letter questioning the reliability of the data presented in the early-stage trial results of the Russian…

Read More Here

AstraZeneca says should know if vaccine works by year-end if trials resume

AstraZeneca should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker's chief executive Pascal Soriot said on Thursday, as long as…

Read More Here

UK says other vaccine trials also likely to be paused

Other COVID-19 vaccine trials are likely to be paused at some point the British government’s Chief Scientific Adviser Patrick Vallance, said, describing a pause in the trial of an AstraZeneca…

Read More Here

India weighing Russian offer for Sputnik-V vaccine trial, manufacturing

India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said.…

Read More Here

Australia says not worried about AstraZeneca’s suspension of COVID vaccine trials

AstraZeneca Plc's suspension of its COVID-19 vaccine trials after a participant's unexplained illness did not mean the vaccine had been scrapped and showed safety standards were being adhered to, Australia's…

Read More Here

China’s CanSino defends coronavirus vaccine candidate after experts cast doubt

China's CanSino Biologics Inc said on Wednesday that expert opinion on its high-profile coronavirus vaccine candidate should not be followed "blindly" without sufficient clinical trial data. Scientists outside the company…

Read More Here

Inovio partners with Thermo Fisher to bolster COVID-19 vaccine supply

Inovio Pharmaceuticals Inc announced that Thermo Fisher Scientific would manufacture the drug developer's experimental coronavirus vaccine, as it looks to boost the supply ahead of large trials this month. The…

Read More Here

UPDATED: WHO says vaccine safety top priority, as AstraZeneca pauses study

Safety of a prospective vaccine for COVID-19 comes "first and foremost", the World Health Organization's chief scientist said on Wednesday, as a trial of a candidate from AstraZeneca was paused,…

Read More Here

UK health minister says pause in AstraZeneca vaccine trial not necessarily a setback

Britain's Health Secretary Matt Hancock said on Wednesday that AstraZeneca's decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a…

Read More Here

U.S., European COVID vaccine developers make pledge to uphold testing rigour

Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards that their experimental immunisations will be held against, amid a hurried global race to contain…

Read More Here

AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concern

AstraZeneca Plc announced it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant. "Our standard review process was…

Read More Here

Coronavirus vaccine development status update

Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held against in the global race to contain the coronavirus…

Read More Here

Australia expects to receive AstraZeneca’s COVID-19 vaccine within months

Australia expects to receive its first batches of a potential COVID-19 vaccine in January, Prime Minister Scott Morrison said on Monday, as the number of new daily infections in the…

Read More Here

How common cold viruses are being used in vaccines from Russia, China

The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China’s CanSino Biologics and Russia’s Gamaleya Institute have been studied for decades, but are still not widely used. The…

Read More Here

90% of China’s Sinovac employees, families took coronavirus vaccine

About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country's emergency use programme, its chief executive…

Read More Here

Future COVID-19 vaccine seen below 10 euros – Sanofi

Sanofi's chief in France, Olivier Bogillot, said on Saturday that its future COVID-19 vaccine was likely to be priced below 10 euros per shot. "The price is not totally set…

Read More Here

Astrazeneca to begin Phase 1/2 clinical trials of coronavirus vaccine in Japan

Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate. Trials of the vaccine, known as AZD1222, will be conducted at multiple…

Read More Here

Results of Russia’s COVID-19 vaccine produced antibody response – The Lancet

Russia's "Sputnik-V" COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow…

Read More Here

UPDATED: WHO warns widespread COVID vaccinations not expected until mid-2021

The World Health Organization does not expect widespread vaccinations against COVID-19 until the middle of next year, a spokeswoman said on Friday, stressing the importance of rigorous checks on their…

Read More Here

EU hopeful first vaccine doses will come by end of year

The European Union hopes it will get 30 million doses of a potential COVID-19 vaccine by the end of the year, the first batch in a deal struck with British…

Read More Here

Covid-19 vaccine group says 76 rich countries now committed to ‘COVAX’ access plan

Seventy-six wealthy nations are now committed to joining a global COVID-19 vaccine allocation plan co-led by the World Health Organization (WHO) that aims to help buy and fairly distribute the…

Read More Here

Sanofi and GSK launch trial for COVID-19 protein-based vaccine

French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the COVID-19 pandemic.…

Read More Here

U.S.A. preparing for COVID-19 vaccine distribution by November

The U.S. Centers for Disease Control and Prevention (CDC) has asked state public health officials to prepare to distribute a potential coronavirus vaccine to high-risk groups as soon as late…

Read More Here

Scientists see downsides to top COVID-19 vaccines from Russia, China

High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their…

Read More Here

US says it will not join global effort to find COVID-19 vaccine

The White House on Tuesday pushed back on concerns expressed by the World Health Organization (WHO) after a U.S. health official said a coronavirus vaccine might be approved without completing…

Read More Here

EU donates €400 million to global access cause for Coronavirus vaccine

The European Commission contributed €400 million in guarantees to support the Covid-19 Global Access (COVAX) facility yesterday. The organisation seeks to provide universal access to affordable coronavirus vaccination, treatment and…

Read More Here

Sanofi more confident about its coronavirus vaccines

Sanofi’s confidence in its coronavirus vaccine candidates has increased this summer as the French drugmaker prepares to start clinical trials, its chief executive told Reuters. The company is working on…

Read More Here

Malta secures 330,000 Covid-19 vaccine doses – Minister Fearne

Deputy Prime Minister and Minister for Health Chris Fearne announced that Malta has secured an allocation of 330,000 vaccine doses, once this is successfully developed and made available. In a…

Read More Here

U.S. doctors group calls for transparency in COVID-19 vaccine development

The rapid pace of COVID-19 vaccine development and scant information about the U.S. Food and Drug Administration's (FDA) vaccine review process are leading to concerns, the American Medical Association (AMA)…

Read More Here

Sinovac’s coronavirus vaccine candidate reportedly approved for emergency use in China

. Sinovac Biotech Ltd's coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a…

Read More Here

South American presidents agree to team up on COVID-19 vaccine knowledge and access

A group of South America presidents agreed on information sharing and coordination on access to eventual COVID-19 vaccines to counter the virus which has the continent within its grip, Chile’s…

Read More Here

Novavax CEO expects filing for Covid-19 vaccine approval in December

Novavax Inc expects filing for approval of its COVID-19 vaccine candidate in the United States in December, Chief Executive Stanley Erck said in an interview for Czech daily Hospodarske Noviny,…

Read More Here

Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies

Translate Bio Inc said that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA induced immune response in early-stage non-human primate studies. In a regulatory filing, the company…

Read More Here

Mexico signs up to Italian vaccine trial for coronavirus

Mexico is due to take part in clinical trials of an Italian vaccine being developed against the coronavirus, Foreign Minister Marcelo Ebrard announced. Ebrard did not say when Mexico would…

Read More Here

WHO says 172 countries engaging with global COVID-19 vaccine plan

Some 172 countries are engaging with the WHO-led COVAX plan designed to ensure equitable access to COVID-19 vaccines, the World Health Organization said on Monday, but more funding is urgently…

Read More Here

Survey finds most Britons reject COVD-19 “vaccine nationalism”

Most Britons reject COVID-19 "vaccine nationalism", and say they would be willing to wait until health workers in other countries have had vaccines if that would help end the pandemic…

Read More Here

Italy begins testing potential COVID-19 vaccine on volunteers

Italy kicked off human trials of a potential COVID-19 vaccine on Monday, joining a global effort to develop a response to the virus which has shown signs of resurging in…

Read More Here

Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial

Drug developer Moderna Inc said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer U.S. trial testing its COVID-19 vaccine candidate. In a tweet, the company also…

Read More Here